Natixis’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-176,600
| Closed | -$12M | – | 1297 |
|
|
2022
Q3 | $12M | Sell |
176,600
-160,400
| -48% | -$10.9M | 0.06% | 241 |
|
|
2022
Q2 | $10.8M | Sell |
337,000
-267,200
| -44% | -$8.54M | 0.04% | 274 |
|
|
2022
Q1 | $20.9M | Buy |
604,200
+162,620
| +37% | +$5.63M | 0.07% | 253 |
|
|
2021
Q4 | $12.9M | Buy |
441,580
+59,645
| +16% | +$1.75M | 0.04% | 329 |
|
|
2021
Q3 | $9.73M | Buy |
381,935
+103,955
| +37% | +$2.65M | 0.03% | 377 |
|
|
2021
Q2 | $9.74M | Buy |
+277,980
| New | +$9.74M | 0.04% | 281 |
|
|
2017
Q2 | – | Sell |
-54,815
| Closed | -$2.02M | – | 1021 |
|
|
2017
Q1 | $2.02M | Buy |
+54,815
| New | +$2.02M | 0.03% | 308 |
|